Arcturus Therapeutics Correlations

ARCT Stock

USD 17.51 0.58 3.43%

The current 90-days correlation between Arcturus Therapeutics and 89bio Inc is 0.3 (i.e., Weak diversification). The correlation of Arcturus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Arcturus Therapeutics Correlation With Market

Modest diversification

The correlation between Arcturus Therapeutics Holdings and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arcturus Therapeutics Holdings and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcturus Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Moving together with Arcturus Stock

0.82	PDSB	PDS Biotechnology Corp	Pair Corr
0.71	PEPG	PepGen	Pair Corr
0.82	COLL	Collegium Pharmaceutical	Pair Corr

Moving against Arcturus Stock

0.59	PHVS	Pharvaris BV	Pair Corr
0.52	PLRX	Pliant Therapeutics	Pair Corr
0.51	PMVP	Pmv Pharmaceuticals	Pair Corr
0.48	NAMS	NewAmsterdam Pharma	Pair Corr
0.45	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.42	ESLAW	Estrella Immunopharma	Pair Corr
0.41	LPTX	Leap Therapeutics	Pair Corr
0.68	VREX	Varex Imaging Corp	Pair Corr
0.63	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.6	AGIO	Agios Pharm	Pair Corr
0.59	AVTE	Aerovate Therapeutics	Pair Corr
0.58	CRVS	Corvus Pharmaceuticals	Pair Corr
0.41	ANTX	AN2 Therapeutics	Pair Corr

Related Correlations Analysis

	ETNB	MDGL	PLRX	ACLX	STOK	NTLA	BEAM	CRBU	CRSP	FATE
ETNB		0.73	0.65	0.26	0.41	-0.11	0.6	0.82	0.7	-0.2	ETNB
MDGL	0.73		0.37	0.45	-0.04	-0.59	0.5	0.7	0.59	-0.6	MDGL
PLRX	0.65	0.37		0.5	0.07	-0.28	0.11	0.52	0.64	-0.39	PLRX
ACLX	0.26	0.45	0.5		-0.36	-0.49	0.3	0.49	0.66	-0.61	ACLX
STOK	0.41	-0.04	0.07	-0.36		0.6	0.31	0.21	0.05	0.58	STOK
NTLA	-0.11	-0.59	-0.28	-0.49	0.6		0.16	-0.17	-0.22	0.9	NTLA
BEAM	0.6	0.5	0.11	0.3	0.31	0.16		0.63	0.58	0.03	BEAM
CRBU	0.82	0.7	0.52	0.49	0.21	-0.17	0.63		0.8	-0.23	CRBU
CRSP	0.7	0.59	0.64	0.66	0.05	-0.22	0.58	0.8		-0.28	CRSP
FATE	-0.2	-0.6	-0.39	-0.61	0.58	0.9	0.03	-0.23	-0.28		FATE
	ETNB	MDGL	PLRX	ACLX	STOK	NTLA	BEAM	CRBU	CRSP	FATE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FATE	+ 0.9	NTLA
CRBU	+ 0.82	ETNB
CRSP	+ 0.8	CRBU
MDGL	+ 0.73	ETNB
CRSP	+ 0.7	ETNB
CRBU	+ 0.7	MDGL

High negative correlations

FATE	- 0.61	ACLX
FATE	- 0.6	MDGL
NTLA	- 0.59	MDGL
NTLA	- 0.49	ACLX
FATE	- 0.39	PLRX
STOK	- 0.36	ACLX

Risk-Adjusted Indicators

There is a big difference between Arcturus Stock performing well and Arcturus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arcturus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ETNB	2.69	(0.25)	(0.01)	0.02	3.33	(3.24)	5.01	(6.35)	27.43
MDGL	2.70	0.44	0.15	1.41	2.13	(3.76)	5.17	(3.96)	30.27
PLRX	2.74	(0.14)	0.00	0.05	3.11	(2.94)	5.37	(5.55)	24.35
ACLX	2.41	0.12	0.08	0.17	2.84	(2.57)	6.28	(5.68)	15.13
STOK	2.61	(0.33)	0.00	(0.13)	0.00	0.00	4.68	(6.99)	21.35
NTLA	3.20	(0.86)	0.00	(0.19)	0.00	0.00	5.01	(7.15)	27.28
BEAM	3.14	(0.23)	0.00	0.04	3.58	(3.71)	7.56	(7.94)	20.75
CRBU	3.65	(0.20)	0.00	0.05	4.65	(4.03)	8.91	(6.63)	28.53
CRSP	2.03	(0.07)	0.00	0.07	2.43	(2.21)	5.26	(4.25)	16.95
FATE	4.47	(0.31)	0.00	(0.02)	0.00	0.00	10.74	(7.26)	22.40

Arcturus Therapeutics Corporate Management

Roberta Duncan	Chief Officer	Profile
Lance Kurata	Chief Officer	Profile
FCPh MD	Chief Officer	Profile
Kyle Gutstadt	Analyst PR	Profile
Joseph Roberts	Controller	Profile
Andrew MBA	CFO Director	Profile
Joseph MSc	President, Founder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC